Compare · CCEL vs GBNH
CCEL vs GBNH
Side-by-side comparison of Cryo-Cell International Inc. (CCEL) and Greenbrook TMS Inc. (GBNH): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CCEL and GBNH operate in Misc Health and Biotechnology Services (Health Care), so they compete in similar markets.
- CCEL is the larger of the two at $83.3M, about 1.2x GBNH ($69.8M).
- CCEL has hit the wire 2 times in the past 4 weeks while GBNH has been quiet.
- Company
- Cryo-Cell International Inc.
- Greenbrook TMS Inc.
- Price
- $3.59-2.18%
- $0.12-39.60%
- Market cap
- $83.3M
- $69.8M
- 1M return
- +16.56%
- -
- 1Y return
- -36.46%
- -
- Industry
- Misc Health and Biotechnology Services
- Misc Health and Biotechnology Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2022
- News (4w)
- 2
- 0
- Recent ratings
- 0
- 0
Cryo-Cell International Inc.
Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, kidney, ALS, wound healing, and auto-immune diseases. The company also manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It stores approximately 500,000 cord blood and cord tissue stem cells worldwide. The company markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. Cryo-Cell International, Inc. was incorporated in 1989 and is headquartered in Oldsmar, Florida.
Greenbrook TMS Inc.
Greenbrook TMS Inc., together with its subsidiaries, controls and operates a network of outpatient mental health services centers in the United States. Its centers specialize in the provision of transcranial magnetic stimulation therapy, an FDA-cleared non-invasive therapy for the treatment of depression and related psychiatric services. The company operates approximately 128 treatment centers. Greenbrook TMS Inc. was founded in 2011 and is headquartered in Toronto, Canada.
Latest CCEL
- SEC Form 10-Q filed by Cryo-Cell International Inc.
- Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2026 Financial Results
- Cryo-Cell International Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Regulation FD Disclosure, Financial Statements and Exhibits
- Cryo-Cell Receives NYSE American Continued Listing Notice
- SEC Form 10-K filed by Cryo-Cell International Inc.
- Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2025
- SEC Form 4 filed by Chairman, Co-CEO Portnoy David
- SEC Form 4 filed by Co-CEO Portnoy Mark L.
- SEC Form 4 filed by Chief Information Officer Mikulinsky Oleg
- SEC Form 4 filed by VP Finance, CFO Taymans Jill M
Latest GBNH
- Greybrook Announces Passing of Founder Elias Vamvakas
- Greenbrook TMS Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits
- SEC Form 3 filed by new insider Crish Andrew
- Greenbrook TMS Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits
- Greenbrook TMS Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits
- SEC Form SC 13D/A filed by Greenbrook TMS Inc. (Amendment)
- SEC Form SC 13D/A filed by Greenbrook TMS Inc. (Amendment)
- Greenbrook TMS Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
- SEC Form 424B5 filed by Greenbrook TMS Inc.
- Why MercadoLibre Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session